This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chairman and chief executive officer, and Cory Douglas, chief financial officer, will participate in two upcoming investor conferences in September.
Raymond James European Investors North American Equities Conference
Date: Tuesday, September 10, 2013 at 10:55 a.m. UK Time (5:55 a.m. ET)
Location: London, England
Participants: Tarek Sherif and Cory Douglas
Deutsche Bank 2013 Technology Conference
Date: Wednesday, September 11, 2013 at 7:30 a.m. PT (10:30 a.m. ET)
Location: Las Vegas, NV
Participant: Cory Douglas
Live audio webcasts for the Raymond James European Investors North American Equities Conference and Deutsche Bank 2013 Technology Conference will be available on the “Investor” section of Medidata’s website at
http://investor.mdsol.com. Please visit the website at least 15 minutes prior to each event to register, download and install any necessary audio or video software to access the presentations. For those unable to participate in the live webcasts, replays will be archived on the “Investor” section of Medidata’s website at
http://investor.mdsol.com for a limited period of time following the conferences.
About Medidata SolutionsMedidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.